ABSTRACT
On February 1, 2016, the World Health Organization declared that the cluster of microcephaly cases and other neurological disorders constitute public health emergency of international concern. Furthermore, few studies demonstrated that there was an increased evidence of causal relationship of Zika virus (ZIKAV) infection and microcephaly, birth abnormalities and neurological disorders such as Guillain–Barré syndrome. ZIKAV transmission occurs mainly by the bite of infected mosquitos (Aedes species), but there are also reports that infections could occur via the placenta, breast milk, saliva, blood transfusion and sex. This article reviews the global efforts, progress in scientific research to understand the pathogenesis of ZIKAV infection & disease, clinical presentations, congenital transmission and autoimmune neurological disorders. The paper further explores the knowledge gaps, future priority research agenda for strategic response including vector control and prevention. We conducted a systematic literature review to synthesise available evidence on ZIKAV infection and its vector and host interaction from electronic databases.
ABSTRACT
The Ebola virus was identified in the year 1976 and has caused periodic outbreaks in West African countries. The disease has a case fatality rate up to 90%. Ebola has been classified as a biosafety level four pathogen and there is no currently approved vaccine or treatment for the virus. However, remarkable progress has been demonstrated by researchers in understanding the pathogenicity of the Ebola virus. Several animal models have been cultivated to develop diagnostics, vaccines and therapeutic drugs.
ABSTRACT
The Ebola virus was identified in the year 1976 and has caused periodic outbreaks in West African countries. The disease has a case fatality rate up to 90%. Ebola has been classified as a biosafety level four pathogen and there is no currently approved vaccine or treatment for the virus. However, remarkable progress has been demonstrated by researchers in understanding the pathogenicity of the Ebola virus. Several animal models have been cultivated to develop diagnostics, vaccines and therapeutic drugs.
ABSTRACT
Background: Insecticide Treated Nets (ITNs) reduce malaria related mortality and morbidity significantly. Taking this into account; the Ethiopian Federal Ministry of Health has been distributing ITNs to malaria prone areas of the country through the support of the Global Fund. Objective: To study distributional coverage and assess the knowledge and utilization of insecticide treated nets in Ethiopia. Methods: A cross-sectional study was conducted in 17 malarious districts targeted for the first phase free distribution of long lasting insecticide treats nets (LLITNs) by the Ministry of Health in 9 administrative regions from October 2005 to September 2006. Region specific list of malarious districts where MOH distributed ITNs was used as the sampling frame for stratified random sampling of districts. One kebele (sub district) was selected from each of the selected districts using simple random sampling; and 15of the total households in the selected kebeles were selected using systematic random sampling. Upon obtaining informed consent from the household head or the oldest person in the household the questionnaire was administered and information was recorded. Data were double entered using EpiData version 3 and analyzed using SPSS version 12. Results: A total of 3131 households were visited; and 51.6of the respondents were males. The overall ITN distribution and utilization were 97.6and 81.6; respectively. The majority of households (53.2) owned a single net per family; highest in Dire Dawa (93.7) and lowest in Afar (17.6). Thirty eight percent of the respondents owned two nets per household. Most of the respondents (91.1) cited that ITNs are useful to control malaria either through prevention of mosquito bites (60) or prevention of the disease (39). Conclusion: ITN distribution; utilization; knowledge of users and its acceptability were good considering the recent introduction of the products. However; the person net ratio gap should be narrowed and emphasis needs to be given to vulnerable groups